Join us at the JPM Healthcare Conference
Jan 13th to 16th, San Francisco
A Revolutionary Fusion of Nanophotonics and AI
Introducing CB-Scout NK™
Cell-Level Insights for
NK-Cell Therapy
Jan 13-16, San Francisco
Blood-Based NK-Cell Therapy Persistence and Efficacy Monitoring
CB-Scout NK™ detects live CAR-expressing donor NK cells in host blood with unparalleled sensitivity, providing non-invasive, real-time insights to evaluate efficacy, optimize treatments, and advance breakthroughs.
mmmm
Integrated Platform
A collaborative platform to streamline the management of monitoring tests for patients and clinical trials.
Powerful Analytics
Comparison of persistence and efficacy across patients and clinical trials.
.png)
.png)
Cell-Level Insights
Comprehensive functional insights including exhaustion, activation, cytotoxicity and CAR expression.
.png)
Detect live CAR-expressing donor NK cells in host blood at concentrations as low as 10.
Gain comprehensive functional insights beyond the reach of PCR.
-6
Pioneering
Rare-Cell Biology
A quantum leap forward in rare-cell analysis
CellsBin™ is revolutionizing cell analysis through its patented groundbreaking fusion of nanophotonics and AI. For the first time, we enable the analysis of massive cell populations with microscopic precision, detecting 1 cell of interest among 10,000,000 others with negligible false positives. CellsBin™ is aiming to reshape cell analysis much like next-generation sequencing has revolutionized genomics.
CellsBin™
Serving major life sciences innovation hubs in the nationwide
Our state-of-the-art service lab in New Haven, equipped with the latest CellsBin™ units, provides unparalleled support to researchers and clinicians. We are excited to announce the upcoming launch of our second service lab in Houston as well.
Service Lab with Four Functional CellsBin™ Units (VEGA™ 1.2)